2016
DOI: 10.1016/j.phrs.2015.12.007
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules

Abstract: For many years, bile acids were thought to only function as detergents which solubilize fats and facilitate the uptake of fat-soluble vitamins in the intestine. Many early observations, however, demonstrated that bile acids regulate more complex processes, such as bile acids synthesis and immune cell function through activation of signal transduction pathways. These studies were the first to suggest that receptors may exist for bile acids. Ultimately, seminal studies by many investigators led to the discovery … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
151
0
2

Year Published

2016
2016
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 195 publications
(155 citation statements)
references
References 191 publications
(235 reference statements)
2
151
0
2
Order By: Relevance
“…This suggest that activation of FXR could ameliorate these symptoms, notably liver cholestasis, because FXR is responsible for regulating bile acid synthesis and transport 49 . A highly potent FXR agonist, 6α-ethyl-chenodeoxycholic acid (6-ECDCA, obetacholic acid), a derivative of the FXR agonist CDCA 112 , was recently approved for the treatment of primary biliary cirrhosis (PBC) and is in late clinical trials for NASH 113115 . PBC is currently treated with UDCA 116 .…”
Section: Fxr As a Drug Targetmentioning
confidence: 99%
“…This suggest that activation of FXR could ameliorate these symptoms, notably liver cholestasis, because FXR is responsible for regulating bile acid synthesis and transport 49 . A highly potent FXR agonist, 6α-ethyl-chenodeoxycholic acid (6-ECDCA, obetacholic acid), a derivative of the FXR agonist CDCA 112 , was recently approved for the treatment of primary biliary cirrhosis (PBC) and is in late clinical trials for NASH 113115 . PBC is currently treated with UDCA 116 .…”
Section: Fxr As a Drug Targetmentioning
confidence: 99%
“…Bile acids also function as ligands for nuclear and G protein-coupled receptors and have important roles as signaling molecules. The best-studied bile acid receptors are the farnesoid X receptor (FXR) and G protein-coupled receptor 1 (GPBAR1; also called TGR5 or membrane-type receptor for bile acids, M-BAR), but the list of bile acid receptors also includes other nuclear receptors, such as the pregnane X receptor (PXR) and vitamin D receptor (VDR), and other G protein-coupled receptors, such as the sphingosine-1-phosphate receptor 2 (S1PR2), and muscarinic receptors M2 and M3 [1,2]. It is important to note that bile acids also signal through α5,β1-integrin [3], and can induce membrane perturbations that activate pathways involving membrane-associated proteins such as NAD(P)H oxidases and Phospholipase A2 [4,5].…”
Section: Introductionmentioning
confidence: 99%
“…The signaling pathways involve the interaction with several nuclear receptors (NRs) and cell surface G-protein-coupled receptors (G-PCRs), including the G protein-coupled bile acid receptor GPBAR1 (also known as TGR5 or M-BAR) (Maruyama et al, 2002; Kawamata et al, 2003; Fiorucci and Distrutti, 2015; Copple and Li, 2016). Among NRs, the farnesoid X receptor (FXR) (Makishima et al, 1999; Parks et al, 1999; Wang et al, 1999) is the master gene that orchestrates BA homeostasis.…”
Section: Introductionmentioning
confidence: 99%